Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity

内科学 内分泌学 米拉贝格伦 医学 褐色脂肪组织 白色脂肪组织 脂解 脂联素 胰岛素 脂肪组织 胰岛素抵抗 膀胱过度活动 替代医学 病理
作者
Alana O’Mara,James W. Johnson,Joyce D. Linderman,Robert J. Brychta,Suzanne McGehee,Laura A. Fletcher,Yael A. Fink,Devika Kapuria,Thomas M. Cassimatis,Nathan Kelsey,Cheryl Cero,Zahraa Abdul Sater,Francesca Piccinini,Alison S. Baskin,Brooks P. Leitner,Hongyi Cai,Corina Millo,William J. Dieckmann,Mary Walter,Norman B. Javitt
出处
期刊:Journal of Clinical Investigation [American Society for Clinical Investigation]
卷期号:130 (5): 2209-2219 被引量:350
标识
DOI:10.1172/jci131126
摘要

BACKGROUNDMirabegron is a β3-adrenergic receptor (β3-AR) agonist approved only for the treatment of overactive bladder. Encouraging preclinical results suggest that β3-AR agonists could also improve obesity-related metabolic disease by increasing brown adipose tissue (BAT) thermogenesis, white adipose tissue (WAT) lipolysis, and insulin sensitivity.METHODSWe treated 14 healthy women of diverse ethnicities (27.5 ± 1.1 years of age, BMI of 25.4 ± 1.2 kg/m2) with 100 mg mirabegron (Myrbetriq extended-release tablet, Astellas Pharma) for 4 weeks in an open-label study. The primary endpoint was the change in BAT metabolic activity as measured by [18F]-2-fluoro-d-2-deoxy-d-glucose (18F-FDG) PET/CT. Secondary endpoints included resting energy expenditure (REE), plasma metabolites, and glucose and insulin metabolism as assessed by a frequently sampled intravenous glucose tolerance test.RESULTSChronic mirabegron therapy increased BAT metabolic activity. Whole-body REE was higher, without changes in body weight or composition. Additionally, there were elevations in plasma levels of the beneficial lipoprotein biomarkers HDL and ApoA1, as well as total bile acids. Adiponectin, a WAT-derived hormone that has antidiabetic and antiinflammatory capabilities, increased with acute treatment and was 35% higher upon completion of the study. Finally, an intravenous glucose tolerance test revealed higher insulin sensitivity, glucose effectiveness, and insulin secretion.CONCLUSIONThese findings indicate that human BAT metabolic activity can be increased after chronic pharmacological stimulation with mirabegron and support the investigation of β3-AR agonists as a treatment for metabolic disease.TRIAL REGISTRATIONClinicaltrials.gov NCT03049462.FUNDINGThis work was supported by grants from the Intramural Research Program of the NIDDK, NIH (DK075112, DK075116, DK071013, and DK071014).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
端庄的猕猴桃完成签到 ,获得积分10
1秒前
一斤完成签到 ,获得积分10
1秒前
Fcs完成签到,获得积分10
2秒前
April完成签到,获得积分10
2秒前
DDD完成签到,获得积分10
3秒前
趁微风不躁完成签到,获得积分10
4秒前
5秒前
weizhi完成签到,获得积分10
5秒前
海绵饱饱完成签到 ,获得积分10
6秒前
7秒前
123的应助被开心德地采纳,获得10
7秒前
RAN发布了新的文献求助10
9秒前
海绵完成签到,获得积分10
9秒前
dr完成签到,获得积分10
10秒前
Zhang发布了新的文献求助10
10秒前
贾香运完成签到 ,获得积分20
11秒前
安静的傲松完成签到,获得积分10
11秒前
想要用不完的积分完成签到,获得积分10
12秒前
阿枫完成签到,获得积分10
12秒前
敖江风云完成签到,获得积分10
12秒前
徐昊楠完成签到,获得积分10
13秒前
Spine脊柱发布了新的文献求助10
14秒前
15秒前
16秒前
16秒前
水墨丹青完成签到 ,获得积分10
16秒前
wang完成签到 ,获得积分10
17秒前
天天快乐的应助被RAN采纳,获得10
19秒前
jiqiangqiang完成签到 ,获得积分10
19秒前
唠叨的逍遥完成签到,获得积分10
19秒前
绿狗玩偶发布了新的文献求助10
20秒前
007完成签到,获得积分10
20秒前
oxygen完成签到,获得积分10
22秒前
tomf完成签到,获得积分0
22秒前
Spine脊柱完成签到,获得积分10
24秒前
26秒前
hodme1完成签到,获得积分10
26秒前
搜集达人的应助被Zhang采纳,获得10
28秒前
绿狗玩偶完成签到,获得积分10
29秒前
cyz完成签到 ,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185571
求助须知:如何正确求助?哪些是违规求助? 9574325
关于积分的说明 21835086
捐赠科研通 7783326
什么是DOI,文献DOI怎么找? 3434597
关于科研通互助平台的介绍 2558985
邀请新用户注册赠送积分活动 2481372